The first once-daily ICS/LABA treatment for asthma and COPD launches in the UK Medical News Today, 10 Jan 2014 GlaxoSmithKline and Theravance, Inc have announced the launch of RELVAR® ELLIPTA® (fluticasone furoate/vilanterol) in the UK…